Noticias de ACON_US

Noticias del mercado

Últimas noticias sobre ACON_US — 238 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ACON_US ✕ 238 resultados
08/05/2026 ACON_US — Stock Titan
Aclarion (ACON) director adds 1,562 shares in open-market purchase
07/05/2026 ACON_US — Investing.com South Africa
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com
07/05/2026 ACON_US — Investing.com Canada
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com
07/05/2026 ACON_US — The Manila Times ES ← EN
Aclarion anuncia la incorporación del primer sitio de práctica privada en Los Ángeles al ensayo CLARITY para acelerar aún más la inscripción

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

07/05/2026 ACON_US — MarketScreener
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
07/05/2026 ACON_US — Yahoo! Finance Canada
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
07/05/2026 ACON_US — news.google.com
Aclarion Announces Addition of First Private Practice Site in Los Angeles Into CLARITY Trial to Further Accelerate Enrollment
07/05/2026 ACON_US — Investing.com
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com
07/05/2026 ACON_US — Stock Titan
Beverly Hills spine practice joins 300-patient back pain trial
07/05/2026 ACON_US — Investing.com Australia
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial By Investing.com
07/05/2026 ACON_US — Investing.com
Aclarion adds Lanman Spinal Neurosurgery to CLARITY trial
07/05/2026 ACON_US — The Manila Times
Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment
06/05/2026 ACON_US — Stock Titan
New Western U.S. director gets 17,000-share Aclarion option
06/05/2026 ACON_US — MarketScreener
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
06/05/2026 ACON_US — Yahoo Finance
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

La expansión del equipo comercial refleja la creciente demanda de Nociscan, respaldada por un crecimiento de tres dígitos en la utilizaciónBROOMFIELD, Colorado, May 06, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" o la "Compañía") (Nasdaq: ACON, ACONW), una empresa de tecnología sanitaria en etapa comercial que está aprovechando biomarcadores y algoritmos patentados de inteligencia aumentada (IA) a través de su plataforma Nociscan®. para ayudar a los médicos a identificar la ubicación del dolor lumbar crónico y respaldar un mejor tratamiento

06/05/2026 ACON_US — The Manila Times
Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.
05/05/2026 ACON_US — Investing.com ES ← EN
Aclarion establece un segundo acuerdo de prueba con Weill Cornell Por Investing.com

Aclarion establishes second trial agreement with Weill Cornell By Investing.com

05/05/2026 ACON_US — Investing.com ES ← EN
Aclarion establece un segundo acuerdo de prueba con Weill Cornell

Aclarion establishes second trial agreement with Weill Cornell

05/05/2026 ACON_US — Investing.com Australia
Aclarion establishes second trial agreement with Weill Cornell By Investing.com
05/05/2026 ACON_US — Investing.com
Aclarion establishes second trial agreement with Weill Cornell By Investing.com

Página 6 de 12

keyboard_arrow_up